Sanofi (SNY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sanofi

    NASDAQ: SNY · Real-Time Price · USD
    47.45
    0.65 (1.39%)
    At close: Sep 09, 2025, 3:59 PM
    47.47
    0.04%
    Pre-market: Sep 10, 2025, 08:39 AM EDT

    Sanofi Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 44.29B 46.03B 45.39B 39.17B
    Cost of Revenue
    		 13.21B 14.24B 13.69B 12.26B
    Gross Profit
    		 31.08B 31.8B 31.7B 26.92B
    Operating Income
    		 7.25B 7.88B 16.79B 8.13B
    Interest Income
    		 189M 546M 206M 40M
    Pretax Income
    		 6.7B 7.15B 10.49B 7.8B
    Net Income
    		 5.56B 5.4B 8.37B 6.22B
    Selling & General & Admin
    		 9.18B 10.77B 10.54B 9.55B
    Research & Development
    		 7.39B 6.73B 6.71B 5.69B
    Other Expenses
    		 7.25B 6.45B 2.57B 2.53B
    Operating Expenses
    		 23.83B 23.94B 19.81B 17.77B
    Interest Expense
    		 749M 1.09B 461M 368M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 37.03B 38.16B -7.29B 30.03B
    Income Tax Expense
    		 1.2B 1.6B 2.01B 1.56B
    Shares Outstanding (Basic)
    		 2.5B 2.5B 2.5B 2.5B
    Shares Outstanding (Diluted)
    		 2.5B 2.51B 2.5B 2.5B
    EPS (Basic)
    		 2.30 2.15 2.69 2.49
    EPS (Diluted)
    		 2.30 2.15 2.69 2.49
    EBITDA
    		 11.03B 12B 14.06B 11.29B
    EBIT
    		 7.45B 8.22B 11.04B 8.16B
    Depreciation & Amortization
    		 3.59B 3.78B 3.7B 3.13B

    Add to Watchlist